Cargando…
Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency
Pyridoxine‐dependent epilepsy (PDE) is a potentially treatable vitamin‐responsive epileptic encephalopathy. The most prevalent form of PDE is due to an underlying genetic defect in ALDH7A1 encoding Antiquitin (ATQ), an enzyme with α‐aminoadipic semialdehyde dehydrogenase (AASADH) activity which faci...
Autores principales: | Kava, Maina P., Bryant, Leah, Rowe, Peter, Lewis, Barry, Greed, Lawrence, Balasubramaniam, Shanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358673/ https://www.ncbi.nlm.nih.gov/pubmed/32685344 http://dx.doi.org/10.1002/jmd2.12121 |
Ejemplares similares
-
Pyridoxine-Dependent Epilepsy and Antiquitin Deficiency Resulting in Neonatal-Onset Refractory Seizures
por: Kaminiów, Konrad, et al.
Publicado: (2021) -
Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine‐dependent epilepsy
por: Crowther, Lisa M., et al.
Publicado: (2022) -
An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
por: Kim, Jiyoung, et al.
Publicado: (2022) -
Pyridoxine dependent epilepsies: new therapeutical point of view
por: Falsaperla, Raffaele, et al.
Publicado: (2017) -
A case for newborn screening for pyridoxine-dependent epilepsy
por: Coughlin, Curtis R., et al.
Publicado: (2022)